RU2000132042A - (±) -Cis-3- (2'-benzimidazolyl) -1,2,2-trimethylcyclopentanecarboxylic acid, which exhibits a hypoglycemic and antidiabetogenic effect - Google Patents

(±) -Cis-3- (2'-benzimidazolyl) -1,2,2-trimethylcyclopentanecarboxylic acid, which exhibits a hypoglycemic and antidiabetogenic effect

Info

Publication number
RU2000132042A
RU2000132042A RU2000132042/14A RU2000132042A RU2000132042A RU 2000132042 A RU2000132042 A RU 2000132042A RU 2000132042/14 A RU2000132042/14 A RU 2000132042/14A RU 2000132042 A RU2000132042 A RU 2000132042A RU 2000132042 A RU2000132042 A RU 2000132042A
Authority
RU
Russia
Prior art keywords
hypoglycemic
benzimidazolyl
cis
exhibits
trimethylcyclopentanecarboxylic acid
Prior art date
Application number
RU2000132042/14A
Other languages
Russian (ru)
Other versions
RU2205826C2 (en
Inventor
Сергей Иванович Мерзликин
Сергей Васильевич Сидоренко
Валентин Петрович Черных
Валерий Васильевич Болотов
Владимир Степанович Бондарь
Федор Георгиевич Яременко
Original Assignee
Национальная фармацевтическая академия Украины
Сергей Иванович Мерзликин
Filing date
Publication date
Application filed by Национальная фармацевтическая академия Украины, Сергей Иванович Мерзликин filed Critical Национальная фармацевтическая академия Украины
Priority to RU2000132042/14A priority Critical patent/RU2205826C2/en
Priority claimed from RU2000132042/14A external-priority patent/RU2205826C2/en
Application granted granted Critical
Publication of RU2205826C2 publication Critical patent/RU2205826C2/en
Publication of RU2000132042A publication Critical patent/RU2000132042A/en

Links

Claims (1)

(±)-Цис-3-(2'-бензимидазолил)-1,2,2-триметилциклопентанкарбоновая кислота формулы(±) -Cis-3- (2'-benzimidazolyl) -1,2,2-trimethylcyclopentanecarboxylic acid of the formula
Figure 00000001
Figure 00000001
проявляющая сахароснижающее и антидиабетогенное действие.exhibiting a hypoglycemic and antidiabetogenic effect.
RU2000132042/14A 2000-12-21 2000-12-21 (±)-cis-3-(2'-benzimidazolyl)-1,2,2-trimethylcyclo- pentane carboxylic acid eliciting sugar-reducing and antidiabetogenic effect RU2205826C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2000132042/14A RU2205826C2 (en) 2000-12-21 2000-12-21 (±)-cis-3-(2'-benzimidazolyl)-1,2,2-trimethylcyclo- pentane carboxylic acid eliciting sugar-reducing and antidiabetogenic effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2000132042/14A RU2205826C2 (en) 2000-12-21 2000-12-21 (±)-cis-3-(2'-benzimidazolyl)-1,2,2-trimethylcyclo- pentane carboxylic acid eliciting sugar-reducing and antidiabetogenic effect

Publications (2)

Publication Number Publication Date
RU2205826C2 RU2205826C2 (en) 2003-06-10
RU2000132042A true RU2000132042A (en) 2003-07-10

Family

ID=29209192

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000132042/14A RU2205826C2 (en) 2000-12-21 2000-12-21 (±)-cis-3-(2'-benzimidazolyl)-1,2,2-trimethylcyclo- pentane carboxylic acid eliciting sugar-reducing and antidiabetogenic effect

Country Status (1)

Country Link
RU (1) RU2205826C2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008017840A1 (en) * 2006-08-08 2008-02-14 Merlion Pharmaceuticals Sa Cyclopentanecarboxylic acid derivatives and their use in the treatment of bacterial infectious diseases
WO2009005483A1 (en) * 2007-07-02 2009-01-08 Mayank Jain Method for treating metabolic syndrome x
WO2009093990A1 (en) * 2008-01-25 2009-07-30 Mayank Jain Benzimidazole derivatives and the use thereof
RU2624872C1 (en) * 2016-05-16 2017-07-07 Общество с ограниченной ответственностью "ВладМиВа" Pharmaceutical antidiabetic composition based on (+)-cis-3-(1h-benzimidazol-2-yl)-1,2,2-trimethylcyclopentane carboxylic acid
RU2645356C1 (en) * 2017-08-15 2018-02-21 Общество с ограниченной ответственностью "Белфармамед" 3-(1h-benzimidazol-2-yl) -1,2,2-trimethyl cyclopentancarbonic acid with cardioprotective activity
RU2687979C1 (en) * 2018-03-19 2019-05-17 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Method of correction of streptozotocin-induced diabetes mellitus in rats using a heterocyclic amide-based drug

Similar Documents

Publication Publication Date Title
JP2002540767A5 (en)
JP2004509615A5 (en)
JP2004531205A5 (en)
JP2003515656A5 (en)
JP2002532892A5 (en)
JP2003522167A5 (en)
JP2003522788A5 (en)
JP2004537871A5 (en)
JP2000343526A5 (en)
JP2004506803A5 (en)
JP2002536520A5 (en)
JP2002521318A5 (en)
JP2002029946A5 (en)
JP2000112158A5 (en)
RU2000132042A (en) (±) -Cis-3- (2'-benzimidazolyl) -1,2,2-trimethylcyclopentanecarboxylic acid, which exhibits a hypoglycemic and antidiabetogenic effect
JP2001100043A5 (en)
JP2000275740A5 (en)
JP2003007517A5 (en)
JP2001000144A5 (en)
JP2002097406A5 (en)
JP2004519554A5 (en)
JP2002502840A5 (en)
JP2000303131A5 (en)
JP2002540241A5 (en)
JP2003073555A5 (en)